Is Your Ophthalmology Medication Workflow Built for Today’s Specialty Therapy Landscape?
November 3, 2026
As ophthalmic specialty therapies become more central to patient care, ophthalmology practices are managing increasingly complex workflows that extend well beyond clinical decision-making.
For many practices, the ability to deliver timely treatment depends on a series of operational steps that must happen before the patient arrives for an appointment. Medication access must be coordinated. Prior authorization and reauthorization requirements may need to be addressed. Product availability must be confirmed. Delivery timing must align with treatment schedules. Inventory, reimbursement, patient affordability, and communication across stakeholders may all need to be managed at the same time.
For high-volume ophthalmology practices, these responsibilities can place significant pressure on staff, scheduling, cash flow, and continuity of care. Even when the physician’s clinical decision is clear, the process required to support treatment may involve multiple systems, teams, and external partners.
That complexity is one reason many practices are taking a closer look at their specialty medication workflows and asking a practical question: Is our current process keeping up?
Specialty medication access is now part of the care experience
Medication access was once viewed largely as a back-office process. In ophthalmology, that distinction is becoming harder to maintain.
For patients who require recurring treatments, timing matters. A delayed authorization, missing documentation, coverage issue, medication availability concern, or delivery problem can affect more than one step in the workflow. It may require staff to follow up with a payor, contact a pharmacy, reschedule an appointment, communicate with the patient or caregiver, or adjust the clinic schedule.
These issues can affect the practice as well as the patient. A process that depends heavily on manual follow-up, disconnected systems, or unclear ownership can create avoidable friction across scheduling, billing, clinical operations, patient communication, and medication coordination.
In a high-volume practice environment, even small disruptions can create meaningful downstream effects.
Where workflow friction often appears
Every ophthalmology practice has its own processes, staffing model, patient population, payor mix, and medication access structure. However, many practices may experience friction in similar areas.
One common challenge is medication access and authorization. Prior authorizations, reauthorizations, benefit verification, documentation requirements, and coverage criteria can all influence whether a medication is available when the patient is scheduled for treatment. If the process for identifying requirements, gathering documentation, and communicating authorization status is not clear, delays may occur.
Another challenge is medication availability and delivery timing. Ophthalmology practices often depend on predictable medication availability to support high-volume treatment schedules. When sourcing, delivery coordination, or product availability issues arise late in the process, the practice may have limited time to adjust.
Inventory and financial exposure can also create pressure. Practices managing medications internally may need to consider purchasing, storage, expiration tracking, waste, reimbursement uncertainty, and cash flow. These responsibilities can be manageable individually, but together they may require substantial staff time and consistent oversight.
Staff workflow is another important consideration. Medication access often requires coordination across clinical, scheduling, billing, reimbursement, and patient support teams. When roles are unclear or information does not move efficiently, staff may spend more time on follow-up calls, emails, documentation requests, and issue resolution.
Patient-facing issues matter as well. Patient affordability and support can influence whether patients understand next steps and whether financial concerns are identified early enough to reduce last-minute disruption. Patients may have questions about coverage, out-of-pocket costs, financial support resources, delivery, or medication access status.
Finally, practices need to consider coordination across the practice, pharmacy, and payor. Ophthalmic specialty medication access often requires information to move among multiple stakeholders. When communication is fragmented, teams may encounter repeated information requests, duplicative calls, unclear next steps, or delays in resolving access-related issues.
A more predictable workflow starts with understanding where friction occurs
Many practices know they are experiencing workflow pressure, but it may not always be clear where the greatest friction is occurring.
Is the issue prior authorization? Medication availability? Inventory tracking? Reimbursement uncertainty? Patient affordability? Communication between the practice and pharmacy? Lack of visibility across teams? Scheduling disruption?
Without a structured way to evaluate the workflow, practice leaders may end up reacting to individual issues rather than identifying patterns. A single delayed authorization may seem isolated. A medication availability problem may feel like a one-time inconvenience. A patient affordability question may be handled case by case. But over time, these issues can reveal larger process gaps that affect staff workload, scheduling predictability, and patient experience.
A self-assessment can help practices take a more organized look at the full medication access process. Instead of focusing only on one area, practices can evaluate how well their current workflow supports authorization, delivery timing, inventory, patient affordability, staff communication, continuity of care, and coordination across stakeholders.
This kind of review can be useful for physician owners, administrators, operations leaders, billing and reimbursement stakeholders, and cross-functional practice teams. It can help identify where current processes are working well and where additional coordination support may be valuable.
Why coordination matters
Specialty medication management is not only about obtaining a medication. It is about aligning the operational steps needed to support treatment.
A more coordinated medication access process may help practices identify requirements earlier, communicate more clearly across teams, improve visibility into access-related issues, and better coordinate medication delivery with treatment timing. It can also help patients better understand next steps and available support options when coverage or affordability questions arise.
A specialty pharmacy partner can support ophthalmology practices across areas such as benefits investigation, prior authorization and reauthorization coordination, patient-specific medication coordination, delivery timing, patient affordability resource navigation, refill and treatment schedule coordination, and communication among the practice, pharmacy, payor, and patient.
This support does not replace or influence the physician’s independent clinical judgment or prescribing decisions; specialty pharmacy services are intended to support the operational aspects of medication access and fulfillment.
For busy ophthalmology practices, the opportunity is not simply to add another vendor. It is to create a more predictable medication access process that may help reduce avoidable friction and gives staff additional support in managing complex specialty medication logistics.
Download the Specialty Medication Workflow Assessment for Ophthalmology Practices
To help ophthalmology practices evaluate their current workflows, Acelpa Health developed the Specialty Medication Workflow Assessment as an educational resource for ophthalmology practices.
This practical self-assessment is designed to help practices identify where medication access, authorization, inventory, scheduling, and patient support friction may be occurring.
The assessment covers seven key areas:
- Medication Access & Authorization
- Medication Availability & Delivery Timing
- Inventory & Financial Exposure
- Staff Workflow & Administrative Workload
- Patient Affordability & Support
- Treatment Scheduling & Workflow Predictability
- Coordination Across Practice, Pharmacy, and Payor
After completing the assessment, practices can review their scores, identify their lowest-scoring sections, and discuss where additional coordination support may be useful.
Download the assessment to evaluate where your ophthalmology medication workflow may be working well and where a more coordinated approach may help support a more predictable medication access experience.
The assessment is provided for informational and workflow-evaluation purposes only. Completion of the assessment does not require or imply a referral, prescription, purchase, or use of Acelpa Health’s services.
This assessment is intended for general informational and workflow-evaluation purposes and is not legal, regulatory, reimbursement, or clinical advice. Practices should consult their applicable legal, compliance, reimbursement, and clinical professionals regarding their specific circumstances.
Disclaimer:
The content provided on this blog is for informational purposes only and does not constitute medical advice, professional advice, or a recommendation regarding any particular course of treatment. While we strive to provide accurate and up-to-date information about the role of specialty pharmacies in the adoption of biosimilars, the information shared here is based on publicly available sources and is not intended to replace professional medical consultation or advice.
©2026 Acelpa Health, LLC. All rights reserved.